How much will the directory of capacity structure adjustment affect the pharmaceutical machinery industry?

[pharmaceutical network market analysis] in recent years, China's manufacturing industry has been upgrading in full swing, but there is still a certain gap with Germany and other manufacturing powers The catalogue of guidance on capacity structure adjustment (2019 version) released recently will be updated to encourage, limit and eliminate capacity, and will be implemented as of January 1, 2020 From the content of the catalog, there are more than 900 entries involving the manufacturing industry, accounting for 60% of the total catalog entries Among them, there are 26 items related to pharmaceutical production capacity, including 6 items of encouragement, 6 items of restriction, 8 items of obsolete production process equipment and 5 items of backward products, and one item is "pharmaceutical cold chain logistics, pharmaceutical logistics quality and safety control technical service" under the project of modern logistics industry It can be seen that in 2020, a number of pharmaceutical production capacity will be encouraged, restricted and eliminated In addition, with the impact of consistency evaluation and the policy of expanding with volume procurement, the pharmaceutical industry will accelerate the elimination competition In this context, pharmaceutical equipment closely related to the pharmaceutical industry is also facing the challenge of upgrading In the long run, as backward pharmaceutical production capacity is gradually eliminated, backward production process equipment includes "hot air drying oven without purification facilities", "ampoule drawing and filling machine not meeting GMP requirements", "manual capsule filling process" and "tower type heavy distilled water device" mentioned in the catalogue ”It is no longer suitable for the upgrading of the pharmaceutical industry The pharmaceutical equipment industry needs to be constantly updated to help the pharmaceutical industry develop with high quality and efficiency Pharmaceutical equipment (picture source: pharmaceutical network) substandard API production units will be eliminated In the category of limitation and elimination of pharmaceutical production capacity, we can see that the production units of vitamin C, vitamin E, paracetamol, norfloxacin, rifampicin and other pharmaceutical products are listed The main reasons include overcapacity, environmental pollution, aging of varieties, backward technology and low added value The author understands that in recent years, with the continuous introduction of environmental protection policies, the pharmaceutical industry, especially the API industry, is facing great pressure It is necessary to do a good job in energy conservation, consumption reduction and emission reduction, and update the process and equipment In the encouraged projects, "energy saving, consumption reduction and emission reduction technology for API production" is mentioned; in the eliminated projects, it is clear that API production units whose environment, occupational health and safety cannot meet the national standards are eliminated The above projects send two signals: in 2020, in the API industry, backward production capacity and low-level repetitive construction will be impacted first At the same time, API equipment that fails to meet the national standards will be eliminated API equipment enterprises need to constantly update process technology and create equipment that more conforms to the national standards and has high added value to meet the needs of API enterprises Neutral borosilicate medical glass is encouraged to develop and produce In the category of encouragement, it refers to "the development and production of new medical packaging materials and technologies" It includes: neutral borosilicate medical glass, functional materials with good chemical stability, degradability and high barrier, new packaging drug delivery systems and drug delivery devices such as aerosol, powder mist, self-administration, pre filling and automatic mixing It is understood that at present, most of China's pharmaceutical glass is still low borosilicate glass, which is relatively easy to react with the liquid medicine, bringing health risks The neutral borosilicate medical glass can eliminate this hidden danger, has good stability, and can prevent the drug from being polluted by the glass According to the data, in 2018, the total amount of medical glass in China is about 300000 tons, of which the use of CBSI is about 22000 ~ 23000 tons, accounting for about 7% ~ 8% With the promotion of the concept of healthy China and the guidance catalogue for the adjustment of production capacity structure to encourage the development and production of neutral borosilicate medical glass, it is expected that the pharmaceutical packaging will continue to upgrade in 2020, further promoting the upgrading of low borosilicate glass to medium borosilicate glass The industry forecasts that in the next 5-10 years, 30% - 40% of China will be upgraded from low borosilicate glass to medium borosilicate glass Medium and high-end pharmaceutical equipment is expected to usher in opportunities With the expansion of volume procurement and the promotion of consistency evaluation, the pattern of pharmaceutical industry has changed, and innovative drugs, high-end generic drugs, etc have become the main development direction In order to meet the production and R & D needs of pharmaceutical enterprises in these directions, medium and high-end pharmaceutical equipment enterprises are expected to usher in more opportunities In the category of encouragement, "development and production of high-end pharmaceutical equipment" is also mentioned It includes: new preparation production equipment such as transdermal absorption and powder mist agent, large-scale bioreactor and auxiliary system, high-efficiency protein separation and purification equipment, high-efficiency extraction equipment of traditional Chinese medicine, continuous production technology and equipment of medicine Conclusion: the insiders believe that in the next decade, high-end equipment manufacturing, medicine and other fields will be the key areas of China's manufacturing industry upgrading As a special equipment manufacturing industry for pharmaceutical production, under the guidance of the guidance catalogue of capacity structure adjustment, it is necessary to keep up with the demand, timely eliminate backward processes and equipment, and constantly update and upgrade, so as to help the pharmaceutical industry develop better.